GVN Announces Two New Executive Appointments

GVN ANNOUNCES TWO NEW EXECUTIVE APPOINTMENTS Strategic Focus On Corporate Partnerships, Content Creation and Thought Leadership Baltimore, MD, USA (May 18, 2023) – The Global Virus Network (GVN) recently appointed Andrea Ridenour as Senior Vice President of Corporate Partnerships & Development and Robert Frederick as Chief Content Officer. “Two of the GVN’s most important strategic…

Read More

On the Pandemic Potential for Influenza Currently Circulating Among Birds and Mammals

The Global Virus Network (GVN) recommends that people in close contact with birds and mammals (wild or farmed) use personal protective equipment and get vaccinated against seasonal influenza.  *             *             * It is nearly impossible to predict if the currently spreading avian influenza will become even better adapted to mammals and spill over to people.…

Read More

Eradicating Polio Will Require Changing the Current Public Health Strategy

Leadership of the Global Virus Network Say Policy Decisions Should Reflect the Science Baltimore, MD, March 6, 2023— The recent public health emergency declarations in New York and London due to polio infections and detection of the virus in these cities’ wastewater strongly indicate that polio is no longer close to being eradicated.Now, four members…

Read More

Why Worry About Avian Flu?

The Covid pandemic is the latest concern regarding potential zoonotic spillover of a dangerous virus. What will actually be the next virus? In the game of spillover roulette, some have put their bets on yet another coronavirus. Lately, however, the smart money seems to be betting on avian flu, or more specifically, H5N1 avian flu.…

Read More

Global Virus Network (GVN) Adds Brazil’s Laboratory for Clinical Research in Neuroinfections at Fiocruz

Baltimore, Maryland, USA, March 1, 2023: The Global Virus Network (GVN), representing 71 Centers of Excellence and 9 Affiliates in 40 countries comprising foremost experts in every class of virus causing disease in humans, and the Oswaldo Cruz Foundation (Fiocruz) in Rio de Janeiro, Brazil announced the addition of the Laboratory for Clinical Research in…

Read More

Global Virus Network (GVN) Leaders Publish STAT Op-Ed with a U.S. Government Call to Action and Road Map for the Future of COVID-19

 BALTIMORE, MD, January 31, 2023: STAT today published “How the Biden Administration’s COVID preparedness policies could narrow America’s political divide” co-authored by leadership of the Global Virus Network (GVN), representing 68 Centers of Excellence and 11 Affiliates in 37 countries, and comprising foremost experts in every class of virus causing disease in humans and some…

Read More

Surge of SARS-CoV-2 Variants in China and USA Further Emphasizes Need for Surveillance, Preparedness, and International Collaborations

BALTIMORE, MD, January 9, 2023: Christian Bréchot, MD, PhD, President of the Global Virus Network (GVN), Associate Vice President for International Partnerships and Innovation at the University of South Florida and Professor of the Division of Infectious Disease, Department of Internal Medicine at USF Health Morsani College of Medicine, the GVN Southeast U.S. Regional Headquarters…

Read More

Flu Vaccines: What Does the Future Hold?

Omicron spinoffs, respiratory syncytial virus (RSV), and influenza (flu) viruses have formed a sort of unholy trinity of respiratory infections. Covid vaccines were initially highly effective against infection, hospitalization, and death, but with the multiplication of new variants, only strong protection against hospitalization and death remains. In a previous Perspective (https://gvn.org/respiratory-syncytial-virus-newly-resurgent/), we noted that the…

Read More

GVN Statement on SARS-CoV-2 Variant BF7

SARS-CoV-2 variants continue to appear worldwide. There is some concern about the variant BF7, shorthand for BA.5.2.1.7, which reportedly is spreading in China. BA.5.2.1.7 is part of the Omicron lineage of SARS-CoV-2 and had been indicated as a potential variant of concern. Recent data from the US CDC and other agencies in other countries, however, show…

Read More